Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
27.7M
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
8.99M
-
Shares change
-
-618K
-
Total reported value, excl. options
-
$36M
-
Value change
-
-$3.1M
-
Number of buys
-
8
-
Number of sells
-
-29
-
Price
-
$4.00
Significant Holders of FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) as of Q2 2019
44 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares as of Q2 2019.
FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.99M shares
of 27.7M outstanding shares and own 32.46% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (4M shares), Avoro Capital Advisors LLC (1.11M shares), 683 Capital Management, LLC (971K shares), Solas Capital Management, LLC (850K shares), EVENTIDE ASSET MANAGEMENT, LLC (720K shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (439K shares), Opaleye Management Inc. (295K shares), UNITED SERVICES AUTOMOBILE ASSOCIATION (230K shares), NORTHERN TRUST CORP (97K shares), and OxFORD Asset Management LLP (75.2K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.